Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans

Journal of Neurophysiology

Volumn 106, Issue 4, 2011, Pages 1637-1643

  Mori, Francesco ^a,b   Ribolsi, Michele ^c   Kusayanagi, Hajime ^a,b   Siracusano, Alberto ^c   Mantovani, Vilma ^d   Marasco, Elena ^d   Bernardi, Giorgio ^a,b   Centonze, Diego ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Glutamate; Synaptic plasticity; Transcranial magnetic stimulation

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ARTICLE; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; EVOKED RESPONSE; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; LONG TERM POTENTIATION; MALE; MOTOR CORTEX; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

ACTION POTENTIALS; ADULT; ALLELES; CARRIER PROTEINS; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; LONG-TERM POTENTIATION; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 80054032039     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00318.2011     Document Type: Article

References (58)

1. Arnold PD, Macmaster FP, Richter MA, Hanna GL, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR. Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res 172: 136-139, 2009.
2. Barkus C, McHugh SB, Sprengel R, Seeburg PH, Rawlins JN, Bannerman DM. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol 626: 49-56, 2010.
3. Butefisch CM, Netz J, Wessling M, Seitz RJ, Homberg V. Remote changes in cortical excitability after stroke. Brain 126:470-481, 2003.
4. Cheeran BJ, Ritter C, Rothwell JC, Siebner HR. Mapping genetic influences on the corticospinal motor system in humans. Neuroscience 164: 156-163, 2009.
5. Chen C, Li X, Wang T, Wang HH, Fu Y, Zhang L, Xiao SF. Association between NMDA receptor subunit 2b gene polymorphism and Alzheimer's disease in Chinese Han population in Shanghai. Neurosci Bull 26: 395-400, 2010.
6. Delvaux V, Alagona G, Gérard P, De Pasqua V, Pennisi G, de Noordhout AM. Post-stroke reorganization of hand motor area: a 1-year prospective follow-up with focal transcranial magnetic stimulation. Clin Neurophysiol 114: 1217-1225, 2003.
7. Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 67: 793-802, 2010.
8. Ding YX, Zhang Y, He B, Yue WH, Zhang D, Zou LP. A possible association of responsiveness to adrenocorticotropic hormone with specific GRIN1 haplotypes in infantile spasms. Dev Med Child Neurol 52: 1028-1032, 2010.
9. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 51: 7-61, 1999.
10. Dorval KM, Wigg KG, Crosbie J, Tannock R, Kennedy JL, Ickowicz A, Pathare T, Malone M, Schachar R, Barr CL. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 6: 444-452, 2007.
11. Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kortüm F, Fritsch A, Pientka FK, Hellenbroich Y, Kalscheuer VM, Kohlhase J, Moog U, Rappold G, Rauch A, Ropers HH, von Spiczak S, Tönnies H, Villeneuve N, Villard L, Zabel B, Zenker M, Laube B, Reis A, Wieczorek D, Van Maldergem L, Kutsche K. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 42: 1021-1026, 2010.
12. Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ, Yuan H, Le P, Lyuboslavsky PN, Micale N, Jørgensen L, Clausen RP, Wyllie DJ, Snyder JP, Traynelis SF. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Mol Pharmacol 72: 907-920, 2007.
13. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T, Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381: 706-709, 1996.
14. Fisher RJ, Nakamura Y, Bestmann S, Rothwell JC, Bostock H. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res 143: 240-248, 2002.
15. Foster KA, McLaughlin N, Edbauer D, Phillips M, Bolton A, Constantine-Paton M, Sheng M. Distinct roles of NR2A and NR2B cytoplasmic tails in long-term potentiation. J Neurosci 30: 2676-2685, 2010.
16. Galehdari H, Pooryasin A, Foroughmand A, Daneshmand S, Saadat M. Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population. J Mol Neurosci 38: 178-181, 2009.
17. Georgi A, Jamra RA, Klein K, Villela AW, Schumacher J, Becker T, Paul T, Schmael C, Höfels S, Klopp N, Illig T, Propping P, Cichon S, Nöthen MM, Schulze TG, Rietschel M. Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatr Genet 17: 308-310, 2007.
18. Gielen M, Siegler Retchless B, Mony L, Johnson JW, Paoletti P. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 459: 703-707, 2009.
19. Greenamyre JT. Glutamatergic influences on the basal ganglia. Clin Neuropharmacol 24: 65-70, 2001.
20. Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, Gur RC, Siegel SJ. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 8: 661-675, 2009.
21. Hogsden JL, Dringenberg HC. Decline of long-term potentiation (LTP) in the rat auditory cortex in vivo during postnatal life: involvement of NR2B subunits. Brain Res 1283: 25-33, 2009.
22. Huang YZ, Chen RS, Rothwell JC, Wen HY. The after-effect of human theta burst stimulation is NMDA receptor dependent. Clin Neurophysiol 118: 1028-1032, 2007.
23. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron 45: 201-206, 2005.
24. Ilić TV, Meintzschel F, Cleff U, Ruge D, Kessler KR, Ziemann U. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol 545: 153-167, 2002.
25. Jiang H, Jia J. Association between NR2B subunit gene (GRIN2B) promoter polymorphisms and sporadic Alzheimer's disease in the North Chinese population. Neurosci Lett 450: 356-360, 2009.
26. Jurinke C, van den Boom D, Cantor CR, Köster H. Automated genotyping using the DNA MassArray technology. Methods Mol Biol 187: 179-192, 2002.
27. Kantrowitz JT, Javitt DC. N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 83: 108-121, 2010.
28. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD. Corticocortical inhibition in human motor cortex. J Physiol 471: 501-519, 1993.
29. Li R, Huang FS, Abbas AK, Wigström H. Role of NMDA receptor subtypes in different forms of NMDA-dependent synaptic plasticity. BMC Neurosci 26: 8-55, 2007.
30. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci 27: 2846-2857, 2007.
31. Lovinger DM. Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 58: 951-961, 2010.
32. Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci 6: 603-614, 2005.
33. Ma YY, Cepeda C, Cui CL. The role of striatal NMDA receptors in drug addiction. Int Rev Neurobiol 89: 131-146, 2009.
34. Mori F, Rossi S, Sancesario G, Codecà C, Mataluni G, Monteleone F, Buttari F, Kusayanagi H, Castelli M, Motta C, Studer V, Bernardi G, Koch G, Bernardini S, Centonze D. Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis. Neuropsychopharmacology 36: 559-568, 2011.
35. Mundo E, Tharmalingham S, Neves-Pereira M, Dalton EJ, Macciardi F, Parikh SV, Bolonna A, Kerwin RW, Arranz MJ, Makoff AJ, Kennedy JL. Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol Psychiatry 8: 241-245, 2003.
36. Nitsche MA, Roth A, Kuo MF, Fischer AK, Liebetanz D, Lang N, Tergau F, Paulus W. Timing-dependent modulation of associative plasticity by general network excitability in the human motor cortex. J Neurosci 27: 3807-3812, 2007.
37. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113, 1971.
38. Paoletti P, Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 7: 39-47, 2007.
39. Peurala SH, Müller-Dahlhaus JF, Arai N, Ziemann U. Interference of short-interval intracortical inhibition (SICI) and short-interval intracortical facilitation (SICF). Clin Neurophysiol 119: 2291-2297, 2008.
40. Porter RH, Greene JG, Higgins DS Jr, Greenamyre JT. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J Neurosci 14: 7192-7199, 1994.
41. Qin S, Zhao X, Pan Y, Liu J, Feng G, Fu J, Bao J, Zhang Z, He L. An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur J Hum Genet 13: 807-814, 2005.
42. Reis J, John D, Heimeroth A, Mueller HH, Oertel WH, Arndt T, Rosenow F. Modulation of human motor cortex excitability by single doses of amantadine. Neuropsychopharmacology 31: 2758-2766, 2006.
43. Rodriguez MC, Obeso JA, Olanow CW. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 44: S175-S188, 1998.
44. Roshan L, Paradiso GO, Chen R. Two phases of short-interval intracortical inhibition. Exp Brain Res 151: 330-337, 2003.
45. Rossini PM, Barker AT, Berardelli A. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91: 79-82, 1994.
46. Rossini PM, Rossini L, Ferreri F. Brain-behavior relations: transcranial magnetic stimulation: a review. IEEE Eng Med Biol Mag 29: 84-95, 2010.
47. Schwenkreis P, Liepert J, Witscher K, Fischer W, Weiller C, Malin JP, Tegenthoff M. Riluzole suppresses motor cortex facilitation in correlation to its plasma level. A study using transcranial magnetic stimulation. Exp Brain Res 135: 293-299, 2000.
48. Schwenkreis P, Witscher K, Janssen F, Addo A, Dertwinkel R, Zenz M, Malin JP, Tegenthoff M. Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability. Neurosci Lett 270: 137-140, 1999.
49. Teo JT, Swayne OB, Rothwell JC. Further evidence for NMDA-dependence of the after-effects of human theta burst stimulation. Clin Neurophysiol 118: 1649-1651, 2007.
50. Valls-Solé J, Pascual-Leone A, Wassermann EM, Hallett M. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol 85: 355-364, 1992.
51. Vucic S, Cheah BC, Krishnan AV, Burke D, Kiernan MC. The effects of alterations in conditioning stimulus intensity on short interval intracortical inhibition. Brain Res 1273: 39-47, 2009.
52. Wittenberg GF. Experience, cortical remapping, and recovery in brain disease. Neurobiol Dis 37: 252-258, 2010.
53. Wu SL, Wang WF, Shyu HY, Ho YJ, Shieh JC, Fu YP, Wu ST, Cheng CW. Association analysis of GRIN1 and GRIN2B polymorphisms and Parkinson's disease in a hospital-based case-control study. Neurosci Lett 478: 61-65, 2010.
54. Yüksel C, Öngür D. Magnetic resonance spectroscopy studies of glutamaterelated abnormalities in mood disorders. Biol Psychiatry 68: 785-794, 2010.
55. Zhao Q, Che R, Zhang Z, Wang P, Li J, Li Y, Huang K, Tang W, Feng G, Lindpaintner K, He L, Shi Y. Positive association between GRIN2B gene and bipolar disorder in the Chinese Han population. Psychiatry Res 185: 290-292, 2011.
56. Ziemann U, Chen R, Cohen LG, Hallett M. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 51: 1320-1324, 1998.
57. Ziemann U, Lönnecker S, Steinhoff BJ, Paulus W. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 40: 367-378, 1996.
58. Ziemann U, Tergau F, Wischer S, Hildebrandt J, Paulus W. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalogr Clin Neurophysiol 109: 321-330, 1998.